Revance Therapeutics (NASDAQ:RVNC) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report sent to investors on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts also recently weighed in on the company. Barclays lowered their price target on Revance Therapeutics from […]
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report sent to investors on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts also recently weighed in on the company. Barclays lowered their price target on Revance Therapeutics from […]
